Because diabetes mellitus is a common comorbidity of atherosclerosis, lower levels of circulating TRAIL were also reported in type-2 diabetes [90,91]; however, TRAIL levels did not reflect early stages of atherosclerosis (as a measure of carotid artery intima-media thickness) in these patients [92]. Here, TNFSF10 is linked to type 2 diabetes mellitus.